Rochester

OptimizeRx Reports Second Quarter 2021 Financial Results, Revenue Up 55% as Leading Pharma Brands Aggressively Seek Improved ROI Through Technology Adoption

Retrieved on: 
Wednesday, August 4, 2021

ROCHESTER, Mich., Aug. 04, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported results for the three months ended June 30, 2021. Quarterly comparisons are to the same year-ago period.

Key Points: 

Foresight Research: Consumer Resistance to Banking AI in Georgia

Retrieved on: 
Tuesday, August 3, 2021
Artificial intelligence, Chatbot, Instant messaging, Natural language parsing, Economy, Applications of artificial intelligence, Bank, Financial adviser, Service industries, Articles

ERICA has been in use for about 4 years, So, Foresight Research wondered about consumer resistance to AI and chatbots and surveyed 400 consumers of banking products and services to find out the resistance to AI in Georgia.

Key Points: 
  • ERICA has been in use for about 4 years, So, Foresight Research wondered about consumer resistance to AI and chatbots and surveyed 400 consumers of banking products and services to find out the resistance to AI in Georgia.
  • To start with, about 85% of all consumers are comfortable with asking banking questions or gathering advice on investments, loans or retirement planning in-person.
  • For gathering information or for asking for advice on loans, retirement planning or investments only 44% would be comfortable using AI.
  • Consumers who are extremely or very satisfied with their banks performance in problem solving, offering financial advice, and digital banking are more likely to express comfort with routine AI and advanced AI applications.

DSS Continues to Grow its Healthcare Segment through $1M Investment in Vivacitas Oncology

Retrieved on: 
Monday, August 2, 2021
Articles, Technology, Science and technology, Bitcoin, Blockchain, Decentralization, Oncology, Cancer

We continue to demonstrate our commitment to addressing unmet needs in human healthcare and wellness through key strategic investments, stated Frank D. Heuszel, CEO of DSS.

Key Points: 
  • We continue to demonstrate our commitment to addressing unmet needs in human healthcare and wellness through key strategic investments, stated Frank D. Heuszel, CEO of DSS.
  • With a rich pipeline of promising assets, Vivacitas provides significant upside potential.
  • Vivacitas Oncology Inc. focuses on developing new treatment options to treat cancers resistant to currently available therapies.
  • DSS is a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets.

Monro, Inc. Announces First Quarter Fiscal 2022 Financial Results

Retrieved on: 
Wednesday, July 28, 2021
Financial accounting, Fiscal year

ROCHESTER, N.Y., July 28, 2021 (GLOBE NEWSWIRE) -- Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, today announced financial results for its first quarter ended June 26, 2021.

Key Points: 
  • Sales for the first quarter of the fiscal year ending March 26, 2022 (fiscal 2022) increased 38.4% to $341.8 million, as compared to $247.1 million for the first quarter of the fiscal year ended March 27, 2021 (fiscal 2021).
  • Excluding litigation settlement costs, operating expenses for the first quarter of fiscal 2022 were 27.5% of sales.
  • Interest expense was $6.9 million for the first quarter of fiscal 2022, as compared to $7.4 million for the first quarter of fiscal 2021.
  • Diluted earnings per share for the first quarter of fiscal 2022 was $.46, compared to $.09 in the first quarter of fiscal 2021.

84 Lumber to Host Hiring Event in Greater Rochester, Seeks to Fill Immediate Openings at Retail Stores, Door Shop

Retrieved on: 
Wednesday, July 28, 2021
84 Lumber, Timber industry, Lumber, Rochester, New York, Greater Rochester, Spectrum News 1 Rochester, Rochester, Geography of New York state), Industry economics), Natural Resources

EIGHTY FOUR, Pa., July 28, 2021 /PRNewswire/ -- 84 Lumber , the nation's largest privately held building materials supplier,is launching a recruitment effort to fill immediate openings at retail stores and a door shop in the greater Rochester area.

Key Points: 
  • EIGHTY FOUR, Pa., July 28, 2021 /PRNewswire/ -- 84 Lumber , the nation's largest privately held building materials supplier,is launching a recruitment effort to fill immediate openings at retail stores and a door shop in the greater Rochester area.
  • The company will host a Hiring Event on August 3rd from 7 a.m. to 5 p.m. at its Rochester retail store (1505 Scottsville Road, Rochester, NY 14623).
  • "84 Lumber is seeking to fill 20 open positions at our Rochester area locations to add to our team of more than 50 employees in the area," said Phil Garuccio, divisional vice president at 84 Lumber.
  • Once you are registered, you will receive an email from 84 Lumber with the link to apply for the desired position.

DSS’s Impact BioMedical to Research Plant-Based Preservation Booster in Collaboration with Thomas Swan Co.

Retrieved on: 
Tuesday, July 27, 2021
Roche, Companies, Industry economics), Economic taxonomy

ROCHESTER, N.Y., July 27, 2021 (GLOBE NEWSWIRE) -- Impact BioMedical, Inc., a wholly-owned subsidiary of Document Security Systems Inc. (NYSE American: DSS), today announced with its scientific research partner Global Research and Discovery Group Sciences, GRDG, a collaboration with Thomas Swan Co., to research its plant-based preservation booster, Procombin.

Key Points: 
  • ROCHESTER, N.Y., July 27, 2021 (GLOBE NEWSWIRE) -- Impact BioMedical, Inc., a wholly-owned subsidiary of Document Security Systems Inc. (NYSE American: DSS), today announced with its scientific research partner Global Research and Discovery Group Sciences, GRDG, a collaboration with Thomas Swan Co., to research its plant-based preservation booster, Procombin.
  • The Procombin collaboration will be with Swan Chemical, the New Jersey-based U.S. subsidiary of Thomas Swan & Co.
    We are excited to enter into this phase of development for Procombin.
  • Our early experimental studies have indicated that Procombin may be of use as a preservation booster.
  • Impact BioMedical, Inc. ("Impact BioMedical") is a wholly owned subsidiary of DSS.

OptimizeRx Sets Second Quarter Fiscal 2021 Conference Call for Wednesday, August 4 at 4:30 p.m. ET

Retrieved on: 
Tuesday, July 27, 2021
Communication, Forward-looking statement

Connecting over half of healthcare providers in theU.S.and millions of patients through a proprietary network, theOptimizeRxdigital health platform helps patients afford and stay on medications.

Key Points: 
  • Connecting over half of healthcare providers in theU.S.and millions of patients through a proprietary network, theOptimizeRxdigital health platform helps patients afford and stay on medications.
  • The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise.
  • Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.
  • The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other material risks.

OptimizeRx Announces Agreement with a Top Pharmaceutical Manufacturer to Use its Evidence-Based Physician Engagement to Solve Lapse in Medical Coverage Barrier for Patients

Retrieved on: 
Wednesday, July 14, 2021
Federal assistance in the United States, Healthcare reform in the United States, Presidency of Lyndon B. Johnson, Liberalism in the United States, Medicare, Government, Health, Public policy

The OptimizeRx platform will leverage RWE to provide visibility to doctors when Medicare patients treatment plans are at risk of lapse due to loss of coverage.

Key Points: 
  • The OptimizeRx platform will leverage RWE to provide visibility to doctors when Medicare patients treatment plans are at risk of lapse due to loss of coverage.
  • Patients often dont know when they are at risk of entering Medicare coverage gaps, resulting in lapses in treatment.
  • Providers dont have real-time visibility on this and, as a result, experience an increased burden in managing treatment plans.
  • Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

Monro, Inc. to Report First Quarter Fiscal 2022 Earnings on July 28, 2021

Retrieved on: 
Wednesday, July 14, 2021
Telephone numbers, Monro Muffler Brake, Toll-free telephone number, NASDAQ, Finance, Service companies, Financial markets

ROCHESTER, N.Y., July 14, 2021 (GLOBE NEWSWIRE) -- Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, will release its fiscal 2022 first quarter earnings on July 28, 2021.

Key Points: 
  • ROCHESTER, N.Y., July 14, 2021 (GLOBE NEWSWIRE) -- Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, will release its fiscal 2022 first quarter earnings on July 28, 2021.
  • The Company will host a conference call and audio webcast on Wednesday, July 28, 2021 at 8:30 a.m. Eastern Time.
  • The conference call may be accessed by dialing 1-877-425-9470 and using the required passcode 13721510.
  • A replay will be available approximately two hours after the recording through Wednesday, August 11, 2021 and can be accessed by dialing 1-844-512-2921 and using the required passcode of 13721510.